CASP2 | Caspase 2, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CASP3 | Caspase 3, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CASP4 | Caspase 4, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
CASP5 | Caspase 5, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
CASP6 | Caspase 6, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Mixed |
CASP7 | Caspase 7, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
CASP8 | Caspase 8, apoptosis-related cysteine peptidase | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CASP9 | Caspase 9, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
CAST | Calpastatin | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CAT | Catalase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CBFA2T3 | Core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Mixed |
CBFB | Core-binding factor, beta subunit | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
CBL | Cbl proto-oncogene, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Mixed |
CBLB | Cbl proto-oncogene B, E3 ubiquitin protein ligase | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
CBLC | Cbl proto-oncogene C, E3 ubiquitin protein ligase | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CCAR1 | Cell division cycle and apoptosis regulator 1 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
CCDC120 | Coiled-coil domain containing 120 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
CCDC6 | Coiled-coil domain containing 6 | Cancer-related genes Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
CCKBR | Cholecystokinin B receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CCL11 | Chemokine (C-C motif) ligand 11 | Cancer-related genes Predicted secreted proteins
| | | | | Mixed |
CCL13 | Chemokine (C-C motif) ligand 13 | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
CCL14 | Chemokine (C-C motif) ligand 14 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCL16 | Chemokine (C-C motif) ligand 16 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CCL18 | Chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCL19 | Chemokine (C-C motif) ligand 19 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
CCL2 | Chemokine (C-C motif) ligand 2 | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CCL21 | Chemokine (C-C motif) ligand 21 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCL23 | Chemokine (C-C motif) ligand 23 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
CCL3 | Chemokine (C-C motif) ligand 3 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CCL4 | Chemokine (C-C motif) ligand 4 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CCL5 | Chemokine (C-C motif) ligand 5 | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CCL7 | Chemokine (C-C motif) ligand 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CCL8 | Chemokine (C-C motif) ligand 8 | Cancer-related genes Predicted secreted proteins
| | | | | Mixed |
CCNA1 | Cyclin A1 | Cancer-related genes Predicted intracellular proteins
| | | | | Group enriched |
CCNA2 | Cyclin A2 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCNB1IP1 | Cyclin B1 interacting protein 1, E3 ubiquitin protein ligase | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CCNB2 | Cyclin B2 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CCND1 | Cyclin D1 | Cancer-related genes Disease related genes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CCND2 | Cyclin D2 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
CCND3 | Cyclin D3 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
CCNE1 | Cyclin E1 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CCNE2 | Cyclin E2 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CCNG1 | Cyclin G1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CCNG2 | Cyclin G2 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
CCNH | Cyclin H | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
CCR10 | Chemokine (C-C motif) receptor 10 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Mixed |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CD14 | CD14 molecule | Cancer-related genes CD markers Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |